These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 20592362)
1. The clinicopathological and prognostic relevance of pyruvate kinase M2 and pAkt expression in breast cancer. Benesch C; Schneider C; Voelker HU; Kapp M; Caffier H; Krockenberger M; Dietl J; Kammerer U; Schmidt M Anticancer Res; 2010 May; 30(5):1689-94. PubMed ID: 20592362 [TBL] [Abstract][Full Text] [Related]
2. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression. Park SS; Kim SW Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359 [TBL] [Abstract][Full Text] [Related]
3. The association between Akt activation and resistance to hormone therapy in metastatic breast cancer. Tokunaga E; Kataoka A; Kimura Y; Oki E; Mashino K; Nishida K; Koga T; Morita M; Kakeji Y; Baba H; Ohno S; Maehara Y Eur J Cancer; 2006 Mar; 42(5):629-35. PubMed ID: 16464571 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer. Aleskandarany MA; Rakha EA; Ahmed MA; Powe DG; Ellis IO; Green AR Breast Cancer Res Treat; 2011 Jun; 127(2):407-16. PubMed ID: 20617378 [TBL] [Abstract][Full Text] [Related]
5. Glucose metabolism and angiogenesis in granulosa cell tumors of the ovary: activation of Akt, expression of M2PK, TKTL1 and VEGF. Schmidt M; Kammerer U; Segerer S; Cramer A; Kohrenhagen N; Dietl J; Voelker HU Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):72-8. PubMed ID: 18394773 [TBL] [Abstract][Full Text] [Related]
6. Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK. Schmidt M; Voelker HU; Kapp M; Krockenberger M; Dietl J; Kammerer U J Cancer Res Clin Oncol; 2010 Feb; 136(2):219-25. PubMed ID: 19655166 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of osteopontin in patients with triple-negative breast cancer. Wang X; Chao L; Ma G; Chen L; Tian B; Zang Y; Sun J Eur J Clin Invest; 2008 Jun; 38(6):438-46. PubMed ID: 18452545 [TBL] [Abstract][Full Text] [Related]
8. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer. Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of Akt, phospho-Akt and BAD expression in primary breast cancer. Al-Bazz YO; Underwood JC; Brown BL; Dobson PR Eur J Cancer; 2009 Mar; 45(4):694-704. PubMed ID: 19138840 [TBL] [Abstract][Full Text] [Related]
10. An immunohistochemical evaluation of phosphorylated Akt at threonine 308 [pAkt(Thr308)] in invasive breast cancer. Magkou C; Mylona E; Theohari I; Giannopoulou I; Papanikolaou E; Markaki S; Nakopoulou L In Vivo; 2007; 21(6):967-72. PubMed ID: 18210742 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy. Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582 [TBL] [Abstract][Full Text] [Related]
12. Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis. Isidoro A; Casado E; Redondo A; Acebo P; Espinosa E; Alonso AM; Cejas P; Hardisson D; Fresno Vara JA; Belda-Iniesta C; González-Barón M; Cuezva JM Carcinogenesis; 2005 Dec; 26(12):2095-104. PubMed ID: 16033770 [TBL] [Abstract][Full Text] [Related]
13. Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors. Tolgay Ocal I; Dolled-Filhart M; D'Aquila TG; Camp RL; Rimm DL Cancer; 2003 Apr; 97(8):1841-8. PubMed ID: 12673709 [TBL] [Abstract][Full Text] [Related]
14. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer. Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015 [TBL] [Abstract][Full Text] [Related]
15. Tumor type M2 pyruvate kinase expression in advanced breast cancer. Lüftner D; Mesterharm J; Akrivakis C; Geppert R; Petrides PE; Wernecke KD; Possinger K Anticancer Res; 2000; 20(6D):5077-82. PubMed ID: 11326672 [TBL] [Abstract][Full Text] [Related]
16. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival. Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124 [TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994 [TBL] [Abstract][Full Text] [Related]
18. Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer. Neri A; Marrelli D; Roviello F; DeMarco G; Mariani F; DeStefano A; Megha T; Caruso S; Corso G; Cioppa T; Pinto E Breast Cancer Res Treat; 2006 Sep; 99(1):77-83. PubMed ID: 16541314 [TBL] [Abstract][Full Text] [Related]
19. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer. Generali D; Fox SB; Brizzi MP; Allevi G; Bonardi S; Aguggini S; Milani M; Bersiga A; Campo L; Dionisio R; Vergoni F; Giardini R; Dogliotti L; Bottini A; Harris AL; Berruti A Clin Cancer Res; 2008 May; 14(9):2673-80. PubMed ID: 18451231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]